导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 33.80% | 132/1050 |
| 近一周 | -0.47% | 353/1104 |
| 近一月 | -2.41% | 424/1103 |
| 近一季 | -12.89% | 803/1092 |
| 近半年 | 15.01% | 208/1070 |
| 近一年 | 36.18% | 143/1018 |
| 近两年 | 96.19% | 220/926 |
| 近三年 | 71.74% | 160/834 |
| 成立以来 | 293.40% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
8.47% 59/1070 |
54.08% 206/1101 |
- - |
- - |
| 2025 | 24.23% 594/1065 |
0.92% 725/1014 |
-4.94% 955/1038 |
33.19% 315/1050 |
-2.78% 599/1065 |
| 2024 | 1.50% 539/1011 |
-4.92% 561/960 |
-2.12% 445/983 |
10.92% 556/991 |
-1.68% 424/1011 |
| 2023 | 9.19% 28/952 |
20.54% 25/880 |
0.89% 140/895 |
-8.83% 543/915 |
-1.52% 197/952 |
| 2022 | -20.38% 340/867 |
-19.64% 500/773 |
-0.61% 710/806 |
-14.73% 549/845 |
16.90% 30/867 |
| 2021 | 28.54% 79/740 |
-7.90% 447/580 |
13.38% 277/659 |
5.48% 121/704 |
16.69% 13/740 |
| 2020 | 29.70% 349/554 |
-3.79% 258/419 |
22.20% 246/466 |
2.81% 391/517 |
7.31% 401/554 |
| 2019 | 52.73% 131/410 |
24.50% 741/1149 |
-8.11% 913/1231 |
12.45% 72/390 |
18.73% 21/410 |
| 2018 | -17.26% 41/349 |
- - |
- - |
- - |
-7.79% 137/1080 |
| 2017 | -14.07% 202/285 |
- - |
- - |
- - |
- - |
| 2016 | -11.88% 78/205 |
- - |
- - |
- - |
- - |
| 2015 | 94.35% 2/151 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 景顺长城中小创精选股票A VS. 东吴新产业精选股票A(580008) |